Renaissance Technologies (RenTech)'s AURA Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 174,200 shares of Aura Biosciences, Inc. (AURA) worth $1.24 M, representing 0.00% of the portfolio. First purchased in 2022-Q4, this medium-term investment has been held for 15 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained a strategic position in AURA, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2026, adding 72,100 shares. Largest reduction occurred in Q3 2024, reducing 57,900 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s Aura Biosciences (AURA) Holding Value Over Time
Track share changes against reported price movement
Quarterly Aura Biosciences (AURA) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +72,100 | Add 70.62% | 174,200 | $7.10 |
| Q1 2026 | -43,100 | Reduce 29.68% | 102,100 | $6.69 |
| Q4 2025 | +47,592 | Add 48.76% | 145,200 | $5.45 |
| Q3 2025 | -33,940 | Reduce 25.80% | 97,608 | $6.18 |
| Q2 2025 | +28,248 | Add 27.35% | 131,548 | $6.26 |
| Q1 2025 | +19,600 | Add 23.42% | 103,300 | $5.86 |
| Q4 2024 | +69,500 | Add 489.44% | 83,700 | $8.22 |
| Q3 2024 | -57,900 | Reduce 80.31% | 14,200 | $8.91 |
| Q2 2024 | +15,000 | Add 26.27% | 72,100 | $7.56 |
| Q1 2024 | +28,600 | Add 100.35% | 57,100 | $7.85 |
| Q4 2023 | +15,000 | Add 111.11% | 28,500 | $8.88 |
| Q3 2023 | -6,000 | Reduce 30.77% | 13,500 | $8.96 |
| Q2 2023 | +9,400 | Add 93.07% | 19,500 | $0.01 |
| Q1 2023 | -3,000 | Reduce 22.90% | 10,100 | $0.01 |
| Q4 2022 | +13,100 | New Buy | 13,100 | $0.01 |
Renaissance Technologies (RenTech)'s Aura Biosciences Investment FAQs
Renaissance Technologies (RenTech) first purchased Aura Biosciences, Inc. (AURA) in Q4 2022, acquiring 13,100 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held Aura Biosciences, Inc. (AURA) for 15 quarters since Q4 2022.
Renaissance Technologies (RenTech)'s largest addition to Aura Biosciences, Inc. (AURA) was in Q2 2026, adding 174,200 shares worth $1.24 M.
According to the latest 13F filing for Q2 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 174,200 shares of Aura Biosciences, Inc. (AURA), valued at approximately $1.24 M.
As of the Q2 2026 filing, Aura Biosciences, Inc. (AURA) represents approximately 0.00% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in Aura Biosciences, Inc. (AURA) was 174,200 shares, as reported at the end of Q2 2026.